Cargando…

Impact of SARS-CoV-2 on neuropsychiatric disorders

Evolving data show a variable expression of clinical neurological manifestations in patients suffering with coronavirus disease 2019 (COVID-19) from early disease onset. The most frequent symptoms and signs are fatigue, dizziness, impaired consciousness, ageusia, anosmia, radicular pain, and headach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson-Agramonte, Maria de los Angeles, Gonçalves, Carlos-Alberto, Noris-García, Elena, Préndes Rivero, Naybí, Brigida, Anna Lisa, Schultz, Stephen, Siniscalco, Dario, García García, Ramiro Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311516/ https://www.ncbi.nlm.nih.gov/pubmed/34327127 http://dx.doi.org/10.5498/wjp.v11.i7.347

Ejemplares similares

Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
por: NORIS-GARCÍA, ELENA, et al.
Publicado: (2022)

COVID-19 and the Nervous System from a Cuban Experience
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2023)

Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021)

COVID-19 neuropsychiatric repercussions: Current evidence on the subject
por: da Silva Júnior, Ronaldo Teixeira, et al.
Publicado: (2022)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Peripheral Inflammatory Markers Contributing to Comorbidities in Autism
por: Inga Jácome, Martha Cecilia, et al.
Publicado: (2016)

Neuropsychiatric issues after stroke: Clinical significance and therapeutic implications
por: Zhang, Shuo, et al.
Publicado: (2020)

The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico
por: García-López, Rodrigo, et al.
Publicado: (2022)

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
por: Siniscalco, Dario, et al.
Publicado: (2018)

Connecting brain and body: Transdiagnostic relevance of connective tissue variants to neuropsychiatric symptom expression
por: Sharp, Harriet Emma Clare, et al.
Publicado: (2021)

Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: A cause of concern
por: De Berardis, Domenico, et al.
Publicado: (2022)

Monitoring COVID‐19 through SARS‐CoV‐2 quantification in wastewater: progress, challenges and prospects
por: Alhama, José, et al.
Publicado: (2021)

Induced pluripotent stem cells as a cellular model for studying Down Syndrome
por: Brigida, Anna Lisa, et al.
Publicado: (2016)

Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention
por: de Bardet, Javier Curi, et al.
Publicado: (2023)

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
por: Brigida, Anna Lisa, et al.
Publicado: (2017)

Molecular mechanisms implicated in SARS-CoV-2 liver tropism
por: Quarleri, Jorge, et al.
Publicado: (2022)

Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
por: Schultz, Stephen, et al.
Publicado: (2021)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020)

SARS-CoV-2, surgeons and surgical masks
por: Khalil, Mohammad Ibrahim, et al.
Publicado: (2021)

Insights into the virologic and immunologic features of SARS-COV-2
por: Polat, Ceylan, et al.
Publicado: (2021)

Experimental Models for SARS-CoV-2 Infection
por: Kim, Taewoo, et al.
Publicado: (2021)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Effect of SARS-CoV-2 infection on the liver
por: Sanyaolu, Adekunle, et al.
Publicado: (2023)

Autoimmune liver diseases and SARS-CoV-2
por: Sgamato, Costantino, et al.
Publicado: (2023)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
por: Babiker, Ahmed, et al.
Publicado: (2021)

Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
por: Jung, Min Kyung, et al.
Publicado: (2021)

Bidirectional interplay between SARS-CoV-2 and autophagy
por: Zhou, Hao, et al.
Publicado: (2023)

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy
por: Muñoz de Nova, José Luis, et al.
Publicado: (2022)

Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2
por: Zhang, Xiang-Ning, et al.
Publicado: (2021)

Count on us: T cells in SARS-CoV-2 infection and vaccination
por: Kedzierska, Katherine, et al.
Publicado: (2022)

Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2
por: Simsek, Cem, et al.
Publicado: (2021)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis
por: Zippi, Maddalena, et al.
Publicado: (2020)

Interaction between hepatitis B virus and SARS-CoV-2 infections
por: Xiang, Tian-Dan, et al.
Publicado: (2021)

The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
por: Soh, Sandrine M., et al.
Publicado: (2021)

Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection
por: Canavero, Isabella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dku5h9kg0s1rfn7ht13j23h9e8